Evaluation of an implementation of PRODIGY phase two

Area of Science:

• Health Informatics
• Clinical Decision Support Systems
• General Practice Technology

Background:

• PRODIGY is a prescribing decision-support tool designed for evidence-based, cost-effective prescribing.
• It aims to improve prescribing practices and patient information dissemination in the UK.
• Following successful pilot phases, a nationwide rollout to UK general practitioners (GPs) was planned.

Purpose of the Study:

• To describe the implementation and evaluation of PRODIGY Phase Two by AAH Meditel, a GP system vendor.
• To assess the impact of software and training improvements on PRODIGY adoption.
• To compare Meditel's Phase Two implementation against other vendors and its own Phase One.

Main Methods:

• Evaluation of PRODIGY Phase Two implementation by AAH Meditel.
• Analysis of detailed log files to assess system usage and patient leaflet issuance.
• Comparison of implementation success rates between vendors and across PRODIGY phases.

Main Results:

• AAH Meditel's Phase Two implementation achieved a 27% usage rate, significantly outperforming other vendors (13%) and its own Phase One (9.3%).
• Patient information leaflets were issued in 5.7% of cases, compared to 2.3% for other vendors and 1.0% for Phase One.
• Detailed log files proved valuable for evaluating implementation effectiveness.

Conclusions:

• AAH Meditel's enhanced PRODIGY implementation in Phase Two demonstrated significant improvements in adoption and patient leaflet use.
• Software and training modifications were key factors in the successful implementation.
• Detailed log file analysis is crucial for optimizing clinical decision-support system deployment.